Compare ArcelorMittal SA (MT) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance

ArcelorMittal SATrade

Regeneron Pharmaceuticals IncTrade

Price performance (Past 24H)

Key statistics

ArcelorMittal SA vs Regeneron Pharmaceuticals Inc — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while Regeneron Pharmaceuticals Inc trades at $680.5 (market cap $70.47B). The key difference: Regeneron Pharmaceuticals Inc is the larger of the two by market cap, and ArcelorMittal SA pays the higher dividend (0.91%). Which is the better fit depends on your goals.

	MT	REGN
Market Cap	$50.01B	$70.47B
Sector	Basic Materials	Health
52-Week High	$71.65	$812.27
52-Week Low	$30.39	$545.46
Enterprise Value	$59.33B	$64.42B
Dividend Yield	0.91%	0.56%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

View details →

REGN

Telix reports Q2 revenue of $247M, strong growth, and advances in cancer therapy trials.GlobeNewsWire · 1 day agoBullish Lawsuit alleges Regeneron misled investors on drug trial results, causing stock to drop sharply.GlobeNewsWire · 4 days agoBearish Class action lawsuit filed against Regeneron over misleading trial results and stock price drop.GlobeNewsWire · 4 days agoBearish View details →

About ArcelorMittal SA

ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA

About Regeneron Pharmaceuticals Inc

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases